RxDoctor Payments Data

Summer Strickland

Family · Statesboro, GANPI 1427437888

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 93.5% of the total across 126 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 24 manufacturers reported payments, led by Sumitomo Pharma America, Inc. at 26.3% of the total. Reporting peaked in 2022 at $927 and has fallen 70.2% since, to $277 in 2025.

$2,832in general payments, 2019–2025

Across 126 payments — averaging $22.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sumitomo Pharma America, Inc.$744
  • Astellas Pharma US Inc$444
  • Myovant Sciences Inc.$417
  • AbbVie$321
  • Bayer$209
  • Mayne Pharma Commercial LLC$132
  • plus $566 from 18 others

What the payments were for

  • Food & beverage$2,64793%
  • Education$1857%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,832 in reported general payments places this provider in the 85th percentile of 6,258 family providers in Georgia.

See all family providers in Georgia →

Other family in Statesboro

See the full list for Georgia →

Where these figures come from

Is this you, or does something look wrong? →